Is there a rationale for combining angiotensinconverting enzyme inhibitors and calcium antagonists in cardiovascular disease?

This publication has 102 references indexed in Scilit:

• The pathogenesis of atherosclerosis: a perspective for the 1990s
  Nature, 1993
• Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system
  European Heart Journal, 1991
• Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1991
• Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.
  Journal of Clinical Investigation, 1990
• Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide.
  Proceedings of the National Academy of Sciences, 1988
• Vascular endothelial cells synthesize nitric oxide from L-arginine
  Nature, 1988
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells
  Nature, 1988
• The Effects of Ca²⁺Antagonists on Isolated Rat and Rabbit Mesenteric Resistance Vessels.
  Annals of the New York Academy of Sciences, 1988
• The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide
  British Journal of Pharmacology, 1987
• The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
  Nature, 1980